Speaker(s):
M. Amer Swid, MD, Resident Physician, Geisinger - has nothing to disclose.
Haluk Kavus, MD, Resident Physician, Geisinger - has nothing to disclose.
Moderator(s):
Zachary Hoffer, MD, Pathology Residency Program Director, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Explain evidence-based strategies for managing blood component shortages, emphasizing adherence to guidelines during mild shortages and resourcefulness during severe shortages.
- Describe the importance of balancing safety considerations with the need to extend the blood supply during critical shortages, emphasizing the role of sound medical judgment and practical approaches.
- Discuss the limitations of liquid biopsy testing
- Evaluate the possible future use of liquid biopsy testing in Hematolymphoid neoplasms
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Zachary S. Hoffer, MD have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPPA compliant.
Commerical Support for this Session:
None.
Session date:
05/15/2024 - 12:00pm to 1:00pm EDT
Location:
Moran A Conf Room and Microsoft Teams
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation Credit